Sun Pharmaceutical Industries LtdSUNPHARMA:NSI

871.00
0.10 / 0.01 %
1.41m
23.58%
0.5592
Close in INRToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Jul 03 2015 11:28 BST.

Summary

On Friday, Sun Pharmaceutical Industries Ltd (SUNPHARMA:NSI) closed at 871.00, 25.61% above the 52 week low of 693.40 set on Jul 03, 2014.

52-week range
Today
693.40
Jul 03 2014
1,200.8
Apr 07 2015
Open874.40
Day high881.70
Day low868.75
Bid871.00
Offer--
Previous close871.10
Average volume3.02m
Shares outstanding2.41bn
Free float1.09bn
P/E (TTM)39.73
Market cap2.10tn INR
EPS (TTM)21.92 INR
Annual div (IAD)1.50 INR
Annual div yield (IAD)0.17%
Div ex-dateSep 11 2014
Div pay-dateSep 30 2014
Data delayed at least 15 minutes, as of Jul 03 2015 11:28 BST.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Sun Pharmaceutical Industries Ltd+0.69 %+3.56 %+5.44 %+23.58 %+397.69 %
CNX NIFTY IDX+1.24 %+4.30 %+1.07 %+9.98 %+62.02 %
IN/HEALTH CARE+1.28 %+4.87 %+9.38 %+25.71 %+63.62 %
IN/PHARMACEUTICALS+1.37 %+4.87 %+9.44 %+26.61 %+64.91 %
Data delayed at least 15 minutes, as of Jul 03 2015 11:28 BST.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.